Identification of human CYP2C19 residues that confer S-mephenytoin 4'-hydroxylation activity to CYP2C9

Biochemistry
C C TsaoJoyce A Goldstein

Abstract

CYP2C19 is selective for the 4'-hydroxylation of S-mephenytoin while the highly similar CYP2C9 has little activity toward this substrate. To identify critical amino acids determining the specificity of human CYP2C19 for S-mephenytoin 4'-hydroxylation, we constructed chimeras by replacing portions of CYP2C9 containing various proposed substrate recognition sites (SRSs) with those of CYP2C19 and mutating individual residues by site-directed mutagenesis. Only a chimera containing regions encompassing SRSs 1--4 was active (30% of wild-type CYP2C19), indicating that multiple regions are necessary to confer specificity for S-mephenytoin. Mutagenesis studies identified six residues in three topological components of the proteins required to convert CYP2C9 to an S-mephenytoin 4'-hydroxylase (6% of the activity of wild-type CYP2C19). Of these, only the I99H difference located in SRS 1 between helices B and C reflects a change in a side chain that is predicted to be in the substrate-binding cavity formed above the heme prosthetic group. Two additional substitutions, S220P and P221T residing between helices F and G but not in close proximity to the substrate binding site together with five differences in the N-terminal portion of helix I ...Continue Reading

References

Jan 1, 1989·Pharmacology & Therapeutics·G R WilkinsonR A Branch
Oct 20, 1995·Archives of Biochemistry and Biophysics·T H RichardsonE F Johnson

❮ Previous
Next ❯

Citations

Mar 10, 2012·Reproduction, Fertility, and Development·Manoja PretheebanDan Rurak
May 31, 2008·Journal of Biochemistry·Yasunobu WadaSatoru Asahi
Feb 5, 2014·Chemical & Pharmaceutical Bulletin·Tamer Zekry AttiaTadayuki Uno
Jun 20, 2014·Pharmacogenetics and Genomics·Taimour Y LangaeeJulie A Johnson
Jun 11, 2008·European Journal of Medicinal Chemistry·Yuan YaoDa-Fang Zhong
Jun 20, 2012·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Dong SunAn Huang
Aug 4, 2004·Archives of Biochemistry and Biophysics·Hisashi SuzukiAllan E Rettie
Dec 8, 2004·Archives of Biochemistry and Biophysics·Carol A KempMichael J Sutcliffe
May 15, 2007·Drug Metabolism and Pharmacokinetics·Yoshiyuki HanzawaMichinao Mizugaki
Jun 8, 2004·The Journal of Biological Chemistry·Michael R WesterEric F Johnson
Oct 29, 2004·Drug Metabolism and Drug Interactions·David F V LewisMaurice Dickins
Dec 1, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Robert S Foti, Jan L Wahlstrom
Feb 18, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Huijuan WangChao Chen
Oct 17, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Eric F JohnsonEmily E Scott
Apr 25, 2007·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·N HaniokaS Narimatsu
Jul 19, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Toshiro NiwaMasanao Katagiri
Nov 3, 2012·The Journal of Biological Chemistry·R Leila ReynaldEric F Johnson
Sep 7, 2019·International Journal of Molecular Sciences·Ghulam MustafaRebecca C Wade
Dec 24, 2004·Journal of Medicinal Chemistry·Charles W LocusonJeffrey P Jones

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.